Crossmark

Counteracting the effects of <scp>TNF</scp> receptor‐1 has therapeutic potential in Alzheimer's disease

Crossref DOI link: https://doi.org/10.15252/emmm.201708300

Published Online: 2018-02-22

Published Print: 2018-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Steeland, Sophie

Gorlé, Nina

Vandendriessche, Charysse

Balusu, Sriram

Brkic, Marjana

Van Cauwenberghe, Caroline

Van Imschoot, Griet

Van Wonterghem, Elien

De Rycke, Riet

Kremer, Anneke

Lippens, Saskia

Stopa, Edward

Johanson, Conrad E

Libert, Claude

Vandenbroucke, Roosmarijn E https://orcid.org/0000-0002-8327-620X
Funding

Funding for this research was provided by:

Fonds Wetenschappelijk Onderzoek

Alzheimer's Research Foundation

European Cooperation in Science and Technology (BM1402)

Universiteit Gent
License Information

Version of Record valid from 2018-02-22
More Information

Publication History

Received: 2017-07-21

Accepted: 2018-01-18

Published: 2018-02-22